DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity

Autor: Alexandre Belot, Yu Guo, Pinghui Feng, Jun Xie, Hong-Bing Shu, Hansong Xia, Jun Zhao, Li Zhong, Junjie Zhang, Qing Yang, Ting Liu, Mi Li, Xiaona Sun, Isabelle Rouvet, Cheng Peng
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Male
0301 basic medicine
THP-1 Cells
Morpholines
Protein subunit
Science
General Physics and Astronomy
DNA-Activated Protein Kinase
Biology
Virus Replication
medicine.disease_cause
Antiviral Agents
Article
General Biochemistry
Genetics and Molecular Biology

Cell Line
Autoimmunity
03 medical and health sciences
0302 clinical medicine
Immune system
Virology
medicine
Animals
Humans
Simplexvirus
Missense mutation
Phosphorylation
Protein kinase A
Protein Kinase Inhibitors
Innate immunity
Multidisciplinary
Innate immune system
Vesiculovirus
General Chemistry
Fibroblasts
Nucleotidyltransferases
Immunity
Innate

Mice
Inbred C57BL

030104 developmental biology
Viral replication
Chromones
Cancer research
Female
Protein Multimerization
030217 neurology & neurosurgery
RNA
Guide
Kinetoplastida

Signal Transduction
Zdroj: Nature Communications, Vol 11, Iss 1, Pp 1-15 (2020)
Nature Communications
ISSN: 2041-1723
Popis: Upon sensing cytosolic DNA, the enzyme cGAS induces innate immune responses that underpin anti-microbial defenses and certain autoimmune diseases. Missense mutations of PRKDC encoding the DNA-dependent protein kinase (DNA-PK) catalytic subunit (DNA-PKcs) are associated with autoimmune diseases, yet how DNA-PK deficiency leads to increased immune responses remains poorly understood. In this study, we report that DNA-PK phosphorylates cGAS and suppresses its enzymatic activity. DNA-PK deficiency reduces cGAS phosphorylation and promotes antiviral innate immune responses, thereby potently restricting viral replication. Moreover, cells isolated from DNA-PKcs-deficient mice or patients carrying PRKDC missense mutations exhibit an inflammatory gene expression signature. This study provides a rational explanation for the autoimmunity of patients with missense mutations of PRKDC, and suggests that cGAS-mediated immune signaling is a potential target for therapeutic interventions.
The enzyme cGAS induces innate immune responses upon recognition of cytosolic DNA. Here, using in vitro and in vivo models, the authors identify DNA-PK as a negative regulator of cGAS signalling.
Databáze: OpenAIRE